Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans

Autoimmunity

Volumn 46, Issue 2, 2013, Pages 148-156

  Durandy, Anne ^a,b   Cantaert, Tineke ^c   Kracker, Sven ^a,b   Meffre, Eric ^c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Class switch recombination deficiency; Primary immunodeficiency; Tolerance

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL ARTICLE; ENZYME DEFICIENCY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CD40 LIGAND; CYTIDINE DEAMINASE; GENES, RECESSIVE; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOLOGIC DEFICIENCY SYNDROMES; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84873629665     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.750299     Document Type: Article

References (63)

1. Notarangelo, L. D., M. Duse, and A. G. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3: 101-121
2. Durandy, A., N. Taubenheim, S. Peron, and A. Fischer. 2007. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Adv. Immunol. 94: 275-306
3. Korthauer, U., D. Graf, H. W. Mages, et al. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361: 539-541
4. Ferrari, S., S. Giliani, A. Insalaco, et al. 2001. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. USA 98: 12614-12619
5. Levy, J., T. Espanol-Boren, C. Thomas, et al. 1997. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131: 47-54
6. Winkelstein, J. A., M. C. Marino, H. Ochs, et al. 2003. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82: 373-384
7. Revy, P., T. Muto, Y. Levy, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575
8. Petersen-Mahrt, S. K., R. S. Harris, and M. S. Neuberger. 2002. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418: 99-104
9. Bransteitter, R., P. Pham, M. D. Scharff, and M. F. Goodman. 2003. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 100: 4102-4107
10. Basu,U., F. L. Meng, C. Keim, et al. 2011. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 144: 353-363
11. Imai, K., Y. Zhu, P. Revy, et al. 2005. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Clin. Immunol. 115: 277-285
12. Geisberger, R., C. Rada, and M. S. Neuberger. 2009. The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence. Proc. Natl. Acad. Sci. USA 106: 6736-6741
13. Imai, K., G. Slupphaug, W. I. Lee, et al. 2003. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4: 1023-1028
14. Rada, C., J. M. Di Noia, and M. S. Neuberger. 2004. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 16: 163-171
15. Guikema, J. E., E. K. Linehan, D. Tsuchimoto, et al. 2007. APE1-and APE2-dependent DNA breaks in immunoglobulin class switch recombination. J. Exp. Med. 204: 3017-3026
16. Shen, H. M., A. Tanaka, G. Bozek, D. Nicolae, and U. Storb. 2006. Somatic hypermutation and class switch recombination in Msh6(2/2)Ung(2/2) double-knockout mice. J. Immunol. 177: 5386-5392
17. Ehrenstein, M. R., C. Rada, A. M. Jones, C. Milstein, and M. S. Neuberger. 2001. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc. Natl. Acad. Sci. USA 98: 14553-14558
18. Schrader, C. E., J. Vardo, and J. Stavnezer. 2002. Role for Mismatch Repair Proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J. Exp. Med. 195: 367-373
19. Peron, S., A. Metin, P. Gardes, et al. 2008. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J. Exp. Med. 205: 2465-2472
20. Gardes, P., M. Forveille, M. A. Alyanakian, et al. 2012. Human MSH6 deficiency is associated with impaired antibody maturation. J. Immunol. 188: 2023-2029
21. Yan, C. T., C. Boboila, E. K. Souza, et al. 2007. IgH class switching and translocations use a robust non-classical endjoining pathway. Nature 449: 478-482
22. Ta, V. T., H. Nagaoka, N. Catalan, et al. 2003. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 4: 843-848
23. Barreto, V., B. Reina-San-Martin, A. R. Ramiro, K. M. McBride, and M. C. Nussenzweig. 2003. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 12: 501-508
24. Meyers, G., Y. S. Ng, J. M. Bannock, et al. 2011. Activationinduced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc. Natl. Acad. Sci. USA 108: 11554-11559
25. Herve, M., I. Isnardi, Y. S. Ng, et al. 2007. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J. Exp. Med. 204: 1583-1593
26. Suzuki, K., B. Meek, Y. Doi, et al. 2004. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. USA 101: 1981-1986
27. Quartier, P., J. Bustamante, O. Sanal, et al. 2004. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin. Immunol. 110: 22-29
28. Sibilia, J., A. Durandy, T. Schaeverbeke, and J. P. Fermand. 1996. Hyper-IgM syndrome associated with rheumatoid arthritis: report of RA in a patient with primary impaired CD40 pathway. Br. J. Rheumatol. 35: 282-284
29. Wardemann, H., S. Yurasov, A. Schaefer, et al. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377
30. Nemazee, D., and K. A. Hogquist. 2003. Antigen receptor selection by editing or downregulation of V(D)J recombination. Curr. Opin. Immunol. 15: 182-189
31. Menard, L., D. Saadoun, I. Isnardi, et al. 2011. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest. 121: 3635-3644
32. Isnardi, I., Y. S. Ng, I. Srdanovic, et al. 2008. IRAK-4-and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29: 746-757
33. Sauer, A. V., H. Morbach, I. Brigida, et al. 2012. Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy. J. Clin. Invest. 122: 2141-2152
34. Mao, C., L. Jiang, M. Melo-Jorge, et al. 2004. T cellindependent somatic hypermutation in murine B cells with an immature phenotype. Immunity 20: 133-144
35. Han, J. H., S. Akira, K. Calame, et al. 2007. Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors. Immunity 27: 64-75
36. Ueda, Y., D. Liao, K. Yang, A. Patel, and G. Kelsoe. 2007. T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells. J. Immunol. 178: 3593-3601
37. Kuraoka, M., D. Liao, K. Yang, et al. 2009. Activationinduced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome. J. Immunol. 183: 3237-3248
38. Kuraoka, M., T. M. Holl, D. Liao, et al. 2011. Activationinduced cytidine deaminase mediates central tolerance in B cells. Proc. Natl. Acad. Sci. USA 108: 11560-11565
39. Rathmell, J. C., M. P. Cooke, W. Y. Ho, et al. 1995. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4 T cells. Nature 376: 181-184
40. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87: 319-329
41. Schiemann, B., J. L. Gommerman, K. Vora, et al. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293: 2111-2114
42. Mackay, F., S. A. Woodcock, P. Lawton, et al. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697-1710
43. Shlomchik,M. J., A. Marshak-Rothstein, C.B.Wolfowicz,T. L. Rothstein, and M. G. Weigert. 1987. The role of clonal selection and somatic mutation in autoimmunity. Nature 328: 805-811
44. Paul, E., A. Manheimer-Lory, A. Livneh, et al. 1990. Pathogenic anti-DNA antibodies in SLE: idiotypic families and genetic origins. Int. Rev. Immunol. 5: 295-313
45. van Es, J. H., F. H. Gmelig Meyling,W. R. van de Akker, et al. 1991. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J. Exp. Med. 173: 461-470
46. Stott, D. I., F. Hiepe, M. Hummel, G. Steinhauser, and C. Berek. 1998. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome. J. Clin. Invest. 102: 938-946
47. Sims, G. P., H. Shiono, N. Willcox, and D. I. Stott. 2001. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J. Immunol. 167: 1935-1944
48. Wellmann, U., M. Letz, M. Herrmann, et al. 2005. The evolution of human anti-double-stranded DNA autoantibodies. Proc. Natl. Acad. Sci. USA 102: 9258-9263
49. Jiang, C., M. L. Zhao, K. M. Waters, and M. Diaz. 2012. Activation-induced deaminase contributes to the antibodyindependent role of B cells in the development of autoimmunity. Autoimmunity 45: 440-448
50. Jiang, C., J. Foley, N. Clayton, et al. 2007. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol. 178: 7422-7431
51. Jiang, C., M. L. Zhao, and M. Diaz. 2009. Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis. Immunology 126: 102-113
52. Zan, H., J. Zhang, S. Ardeshna, et al. 2009. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination. Autoimmunity 42: 89-103
53. Hase, K., D. Takahashi, M. Ebisawa, et al. 2008. Activationinduced cytidine deaminase deficiency causes organ-specific autoimmune disease. PLoS One 3: e3033
54. Zaheen, A., B. Boulianne, J. Y. Parsa, et al. 2009. AID constrains germinal center size by rendering B cells susceptible to apoptosis. Blood 114: 547-554
55. Morgan, H. D., W. Dean, H. A. Coker, W. Reik, and S. K. Petersen-Mahrt. 2004. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem. 279: 52353-52360
56. Rai, K., I. J. Huggins, S. R. James, et al. 2008. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 135: 1201-1212
57. Bhutani, N., J. J. Brady, M. Damian, et al. 2010. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463: 1042-1047
58. Popp, C.,W. Dean, S. Feng, et al. 2010. Genome-wide erasure of DNA methylation in mouse primordial germcells is affected by AID deficiency. Nature 463: 1101-1105
59. Bennett, C. L., J. Christie, F. Ramsdell, et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21
60. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73
61. Qin, H., K. Suzuki, M. Nakata, et al. 2011. Activationinduced cytidine deaminase expression in CD4 T cells is associated with a unique IL-10-producing subset that increases with age. PLoS One 6: e29141
62. Chan, O. T., L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189: 1639-1648
63. Guo, W., D. Smith, K. Aviszus, et al. 2010. Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J. Exp. Med. 207: 2225-2237